Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
A Debt-Free and Fairly Valued Medical Devices Company
02:42pm, Wednesday, 20'th Jul 2022
LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
Earnings Season Scorecard and Fresh Analyst Research Reports for Chevron, Adobe & AMD
04:31pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Today's Research Daily features update on the Q2 earnings season and new research reports on Chevron (CVX), Adobe (ADBE), AMD (AMD) and 16 other stocks.
3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now
03:36pm, Friday, 15'th Jul 2022 Zacks Investment Research
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.
3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now
12:58pm, Friday, 15'th Jul 2022
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.
3 Stocks Warren Buffett Bought in the Last Big Recession -- Are They Buys Now?
09:52am, Friday, 15'th Jul 2022 The Motley Fool
The stocks that the legendary investor bought during 2008 and 2009 aren't necessarily great picks today.
3 Reasons to Add Accuray (ARAY) Stock to Your Portfolio Now
02:52pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
Cardinal Health's (CAH) New Buyout to Boost Medication Adherence
02:51pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Cardinal Health's (CAH) latest acquisition is expected to significantly improve patients' health outcomes with improved medication adherence and increased satisfaction.
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
03:53pm, Monday, 11'th Jul 2022 Benzinga
Upgrades
For Visteon Corp (NASDAQ:VC), Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. For the first quarter, Visteon had an EPS of $1.09, compared to year-ago quarter EPS of
Now This Analyst Cuts Price Target On Twitter; Here's The Biggest Price Target Changes For Monday
11:47am, Monday, 11'th Jul 2022 Benzinga
Baird cut Twitter, Inc. (NYSE: TWTR) price target from $45 to $33. Twitter shares fell 5.4% to $34.81 in pre-market trading.
Raymond James lowered HCA Healthcare, Inc. (NYSE: HCA) price target from
BDX vs. ALGN: Which Stock Is the Better Value Option?
03:40pm, Friday, 08'th Jul 2022 Zacks Investment Research
BDX vs. ALGN: Which Stock Is the Better Value Option?
BDX vs. ALGN: Which Stock Is the Better Value Option?
01:13pm, Friday, 08'th Jul 2022
BDX vs. ALGN: Which Stock Is the Better Value Option?
BD TO ANNOUNCE FINANCIAL RESULTS FOR ITS THIRD QUARTER OF FISCAL 2022
04:15pm, Thursday, 07'th Jul 2022
FRANKLIN LAKES, N.J. , July 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its third quarter of fiscal year 2022 on Thu
BD's (BDX) New Combination Test to Boost Patient Outcome
02:15pm, Friday, 01'st Jul 2022 Zacks Investment Research
BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.
BD's (BDX) New Combination Test to Boost Patient Outcome
11:31am, Friday, 01'st Jul 2022
BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.
BD (BDX) Integrates Innovative Solution to Boost Patient Care
03:45pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.
